<DOC>
	<DOCNO>NCT01487798</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate difference frequency episodes hypoglycaemia treatment biphasic insulin aspart 30 compare biphasic human insulin 30 subject well control type 2 diabetes .</brief_summary>
	<brief_title>Frequency Episodes Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes Treated insulin 13 injection daily least 6 month Body Mass Index ( BMI ) 40 kg/m^2 HbA1c ( glycosylated haemoglobin A1c ) 9.5 % screen Total insulin dosage 1.8 IU/kg Impaired hepatic renal function significant cardiac problem</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>